...
首页> 外文期刊>Clinical and experimental obstetrics and gynecology >Extracellular matrix metalloproteinases in the etiopathogenesis of endometriosis: a systematic review and critical appraisal
【24h】

Extracellular matrix metalloproteinases in the etiopathogenesis of endometriosis: a systematic review and critical appraisal

机译:细胞外基质金属蛋白酶在子宫内膜异位症的病症中:系统审查和批判性评估

获取原文
获取原文并翻译 | 示例
           

摘要

Despite extensive research in the field, the etiopathogenesis of endometriosis remains an unresolved enigma. The possible role of different enzymes of the extracellular matrix, in particular the role of the matrix metalloproteases or metalloproteinases (MMPs) in the etiopathogenesis and the mechanisms involved in the processes of benign dissemination of endometriosis have been widely investigated in recent years. Various members of the enzymatic system of the MMPs, as well as their inhibitors, termed tissue inhibitors of metalloproteinases (TIMPs) and their inducer, termed extracellular matrix metalloproteinase inducer (EMMPRIN), have been implicated in the mechanisms involved in endometriosis formation, progression, and maintenance. The aim of the present paper was to provide an overview and critical evaluation of existing experimental evidence on this issue. For this purpose the authors have conducted a systematic review of the literature and evaluated relevant papers regarding experimental animal models, in vitro experiments, and analyses in human samples and studies regarding genetic polymorphisms in humans. In conclusion, members of the system of matrix MMPs, their inhibitors and inducers could be useful as novel diagnostic and prognostic biomarkers in determining the severity of endometriosis and response to therapy. Furthermore, in depth knowledge in this field could possibly lead to the development of more efficient treatment modalities. Future research should focus on the systematic investigation of the entire MMPs system in endometriosis, as well as on the interaction between its members.
机译:尽管在该领域进行了广泛的研究,但子宫内膜异位症的病因发生仍然是未解决的谜。近年来,近年来,近年来广泛研究了细胞外基质的不同酶,特别是基质金属蛋白酶或金属蛋白酶(MMP)的作用和涉及所述子宫内膜异位症的良性传播过程的机制。 MMP的酶系统的各种成员以及它们的抑制剂称为金属蛋白酶酶的组织抑制剂(TIMP)及其诱导剂,称为细胞外基质金属蛋白酶诱导剂(EMMPRIN),并涉及所述子宫内膜异位症形成,进展的机制,和维护。本文的目的是提供对本问题现有实验证据的概述和关键评估。为此目的,作者对文献进行了系统审查,并评估了关于实验动物模型,体外实验的相关论文,以及人类样品的分析以及人类遗传多态性的研究。总之,基质MMPS系统,其抑制剂和诱导剂的成员可用作新诊断和预后生物标志物,用于确定子宫内膜异位症的严重程度和对治疗的反应。此外,在该领域的深度知识可能导致开发更有效的治疗方式。未来的研究应专注于对子宫内膜异位症中整个MMPS系统的系统调查,以及其成员之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号